The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease
Abstract
Background The prognostic influences of fibrinogen and C-reactive protein levels and their relations to myocardial damage in unstable coronary artery syndromes have not been well described. Methods and Results Fibrinogen and C-reactive protein were determined at inclusion and related to outcome after 5 months in 965 patients with unstable angina or non–Q-wave myocardial infarction randomized to 5 weeks with low-molecular-weight heparin or placebo. The probabilities of death were 1.6%, 4.6%, and 6.9% ( P =.005) and the probabilities of death and/or myocardial infarction were 9.3%, 14.2%, and 19.1% ( P =.002), respectively, in patients stratified by tertiles of fibrinogen (<3.38, 3.38 to 3.99, and ≥4.0 g/L). The probabilities of death were 2.2%, 3.6%, and 7.5% ( P =.003) after stratification of patient data by tertiles of C-reactive protein level (<2, 2 to 10, and >10 mg/L). In logistic multiple regression analysis, increased fibrinogen levels were independently associated with the incidence of death and/or myocardial infarction ( P =.013), and elevated C-reactive protein level was associated with the incidence of death ( P =.012). The increased relative risk of subsequent death or myocardial infarction in individuals with an elevated fibrinogen level was consistent in most subgroups evaluated; although significantly so only in patients with signs of myocardial damage. Conclusions Increased levels of both fibrinogen and C-reactive protein are associated with a worse outcome in patients with unstable coronary artery disease. The increased risk associated with elevated fibrinogen levels is independent of, and additive to, the prognostic influence of myocardial damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Yarnell, J. W., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., Whitehead, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 916
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY
Meade, T. W., Chakrabarti, R., Haines, A. P., North, W. R. S., Stirling, Y., Thompson, S. G., & Brozović, M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91498-1 · Cited by 690
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
Self-citationFibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 593
Elevation of C-reactive protein in “active” coronary artery disease
Berk, B. C., Weintraub, W. S., & Alexander, R. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90079-g · Cited by 588
Lindahl, B., Venge, P., & Wallentin, L. (1996) · Circulation · doi:10.1161/01.cir.93.9.1651 · Cited by 575
Self-citationHeinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563
International diagnostic criteria for acute myocardial infarction and acute stroke
Gillum, R. F., Fortmann, S. P., Prineas, R. J., & Kottke, T. E. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90558-1 · Cited by 484
Plasma fibrinogen--a major coronary risk factor.
Stone, M. C., & Thorp, J. M. (1985) · PubMed · Cited by 362
Unstable Angina: A Comparison of Angioscopic Findings Between Diabetic and Nondiabetic Patients
Silva, J. A., Escobar, A., Collins, T. J., Ramee, S. R., & White, C. J. (1995) · Circulation · doi:10.1161/01.cir.92.7.1731 · Cited by 230
de Feyter, P. J., Ozaki, Y., Baptista, J., Escaned, J., Di Mario, C., de Jaegere, P. P. T., Serruys, P. W., & Roelandt, J. R. T. C. (1995) · Circulation · doi:10.1161/01.cir.92.6.1408 · Cited by 185
Incidence and follow-up of Braunwald subgroups in unstable angina pectoris
van Miltenburg-van Zijl, A. J. M., Simoons, M. L., Veerhoek, R. J., & Bossuyt, P. M. M. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00009-s · Cited by 163
Arbustini, E., Grasso, M., Diegoli, M., Pucci, A., Bramerio, M., Ardissino, D., Angoli, L., de Servi, S., Bramucci, E., Mussini, A., et al. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90383-v · Cited by 160
Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
Levenson, J., Giral, P., Razavian, M., Gariepy, J., & Simon, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1263 · Cited by 152
Zermansky, A. G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92740-8 · Cited by 147
Burr, M. L., Holliday, R. M., FEHILY, A. M., & WHITEHEAD, P. J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060141 · Cited by 129
Fibrinogen Is a Predictor of Mortality in Coronary Heart Disease Patients
Benderly, M., Graff, E., Reicher-Reiss, H., Behar, S., Brunner, D., & Goldbourt, U. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.3.351 · Cited by 118
The effect of physiological levels of fibrinogen on platelet aggregation
Meade, T. W., Vickers, M. V., Thompson, S. G., & Seghatchian, M. J. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90185-9 · Cited by 104
Becker, R. C., Cannon, C. P., Bovill, E. G., et al. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90386-0 · Cited by 104
Tracy, R. P., Bovill, E. G., Yanez, D., Psaty, B. M., Fried, L. P., HEISS, G. M., Lee, M., Polak, J. F., & Savage, P. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1269 · Cited by 97
Acute phase reaction, fibrinogen level and thrombus size
Chooi, C. C., & Gallus, A. S. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90204-1 · Cited by 48
Association of Recurrent Myocardial Infarction with Hemostatic Factors
Kostis, J. B., Baughman, D. J., & Kuo, P. T. (1982) · CHEST Journal · doi:10.1378/chest.81.5.571 · Cited by 39
Cited by
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Brook, R. D., Franklin, B., Cascio, W., Hong, Y., Howard, G., Lipsett, M., Luepker, R., Mittleman, M., Samet, J., Smith, S. C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128587.30041.c8 · Cited by 2,380
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Metadata
- Authors
- Toss, H., Lindahl, B., Siegbahn, A., Wallentin, L., & Group, F. T. F. S.
- Venue
- Circulation
- Published
- 1997-12-16
- Volume
- 96
- Issue
- 12
- Pages
- 4204-4210
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2008589296
- Cited by
- 520
- References
- 28
- FWCI
- 19.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.